FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Researchers from Mass General Brigham developed olfactory tests—in which participants sniff odor labels that have been placed on a card—to assess people’s ability to discriminate, identify and ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline ...

Apple Ridge Orchard in Sikeston is expanding with a new property acquisition. Owners Trey and Ashley Wilson plan to open a ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...

Westwater Resources Inc (WWR) is expected to report for 4Q. Williams-Sonoma Inc (WSM) is expected to report $2.90 for 4Q. Yunhong Green CTI Ltd (YHGJ) is expected to report for 4Q.

A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...

Equities researchers at Jones Trading began coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a ...

Stock analysts at Lifesci Capital cut their FY2025 earnings per share estimates for Astria Therapeutics in a research report ...